Clinical Trial Update: Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating steroid therapy for myocardial inflammation in scleroderma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction Wait the Condition Is Myocardial Inflammation Associated with Scleroderma Interpreted Disease Name Myocardial Inflammation in Systemic Sclerosis

Drugs mentioned

• Steroid therapy (Corticosteroid)

Snippet

Sponsor: Khon Kaen University | Conditions: Myocardial Inflammation | Phase 2 | Status: COMPLETED